Natalie M. Zahr

Dr. Natalie M. Zahr

Department of Psychiatry and Behavioral Sciences, School of Medicine, Stanford University, Palo Alto, CA 94304, USA
orcid

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 April 2019 in Journal of Neuroscience Research
Verified
Journal Article
Closed access
PDF file
MFMichael Fritz
Michael Fritz
AKAnna M. Klawonn
Anna M. Klawonn
NZNatalie M. Zahr
Natalie M. Zahr

1 August 2017 in Neuropharmacology
Verified
Journal Article
Closed access
NZNatalie M. Zahr
Natalie M. Zahr
APAdolf Pfefferbaum
Adolf Pfefferbaum
ESEdith V. Sullivan
Edith V. Sullivan

26 October 2010 in Alcohol, Clinical and Experimental Research
Verified
Journal Article
Closed access
PDF file
NZNatalie M. Zahr
Natalie M. Zahr
RLRichard Luong
Richard Luong
ESEdith V. Sullivan
Edith V. Sullivan
APAdolf Pfefferbaum
Adolf Pfefferbaum

26 October 2014 in Brain Pathology
Verified
Journal Article
Open access
PDF file
NZNatalie M. Zahr
Natalie M. Zahr
DMDirk Mayer
Dirk Mayer
TRTorsten Rohlfing
Torsten Rohlfing
ESEdith V. Sullivan
Edith V. Sullivan
APAdolf Pfefferbaum
Adolf Pfefferbaum
Neuroinflammatory mechanisms contribute to the brain pathology resulting from human immunodeficiency virus (HIV) infection. Magnetic resonance spectroscopy (MRS) has been touted as a suitable method for discriminatingin vivomarkers of neuroinflammation. The presentMRSstudy was conducted in four groups: alcohol dependent (A, n = 37),HIV‐infected (H, n = 33), alcohol dependent + HIVinfected (HA, n = 38) and healthy control (C, n = 62) individuals to determine whether metabolites would change in a pattern reflecting neuroinflammation. Significant four‐group comparisons were evident only for striatal choline‐containing compounds (Cho) and myo‐inositol (mI), which follow‐up analysis demonstrated were due to higher levels inHAcompared withCindividuals. To explore the potential relevance of elevatedCho andmI, correlations between blood markers, medication status and alcohol consumption were evaluated inH + HAsubjects. Having an acquired immune deficiency syndrome (AIDS)‐defining event or hepatitisCwas associated with higherCho; lowerCho levels, however, were associated with low thiamine levels and with highly active antiretroviralHIVtreatment (HAART). Higher levels ofmIwere related to greater lifetime alcohol consumed, whereasHAARTwas associated with lowermIlevels. The current results suggest that competing mechanisms can influencein vivo Cho andmIlevels, and that elevations in these metabolites cannot necessarily be interpreted as reflecting a single underlying mechanism, including neuroinflammation.


10 January 2013 in Neuropsychopharmacology
Verified
Journal Article
Closed access
NZNatalie M. Zahr
Natalie M. Zahr
DMDirk Mayer
Dirk Mayer
TRTorsten Rohlfing
Torsten Rohlfing
JOJuan Orduna
Juan Orduna
RLRichard Luong
Richard Luong
APAdolf Pfefferbaum
Adolf Pfefferbaum